Atlas Trials

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years

Clinical trial NCT06614816 · COMPLETED

Trial details

NCT number
NCT06614816
Sponsor
Southeast University, China
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chickenpox Vaccines
Start date
2019-02-10
Primary completion
2021-07-15
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.